Skip to content

Anaesthetic onset

Low fresh gas flow during elective general anaesthesia - A pilot study comparing Desflurane and Sevoflurane for anaesthetic controllability during wash-in and for haemodynamic control during elective general surgery.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-004852-13-SE
Enrollment
150
Registered
2014-05-19
Start date
2014-06-24
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anaesthesia time to onset - wash-in

Interventions

Trade Name: Suprane generic name desflurane Pharmaceutical Form: Inhalation vapour Trade Name: Sevorane, generic name sevoflurane Pharmaceutical Form:

Sponsors

Anestesikliniken
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ASA 1-2 patients scheduled for elective general anaesthesia Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 150 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: ASA > 2 and any cardiovascular or pulmonary disease

Design outcomes

Primary

MeasureTime frame
Main Objective: Study time to reach 1 AMC, minimal alveolar concentration;Secondary Objective: Time to reach 1.5 MAC;Primary end point(s): Time to reach 1 MAC during induction;Timepoint(s) of evaluation of this end point: Minutes to reach 1 MAC

Secondary

MeasureTime frame
Secondary end point(s): Time to reach 1.5 MAC surgical anaesthesia;Timepoint(s) of evaluation of this end point: Minutes taken from 1 MAC to 1.5 MAC

Countries

Sweden

Contacts

Public ContactJan Jakobsson

Anestesikliniken

jan.jakobsson@ki.se46702500960

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026